Nonpatentable drugs and the cost of our ignorance. [CMAJ. 2006]

SearchDatabase nameforSearch term

Advanced Search (beta)

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: CMAJ. 2006 Feb 14;174(4):483-4. Links

Erratum in:: CMAJ. 2006 May 9;174(10):1450.

Nonpatentable drugs and the cost of our ignorance.

Calon F.

Molecular Endocrinology and Oncology Research Center, Laval University Medical Center (CHUL), and the Faculty of Pharmacy, Laval University, Sainte-Foy, Qué.

PMID: 16477060 [PubMed - indexed for MEDLINE]

PMCID: PMC1373754

The role of the private sector in biotechnology: research and development. [Health Matrix Clevel. 2002]
The Human Genome Project: a public good. [Health Matrix Clevel. 2002]
Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro. [Am J Bioeth. 2002]
The global drug gap. [Science. 2000]
Global health. Public-private partnerships proliferate. [Science. 2006]
» See all Related Articles...

Display Show

Nonpatentable drugs and the cost of our ignorance.

Related Articles